Plant Comparison
Lingzhi vs Bitter Melon
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Lingzhi and Bitter Melon: they share 6 indicated uses (arthritis / joint pain, blood sugar / diabetes support, cancer (anticancer research), …); 4 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Lingzhi | Bitter Melon | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 1/10 | 5/10 | Stronger for Bitter Melon |
| Blood sugar / diabetes support | 1/10 | 9/10 | Stronger for Bitter Melon |
| Cancer (anticancer research) | 8/10 | 9/10 | Comparable evidence |
| Inflammation (general) | 1/10 | 1/10 | Comparable evidence |
| Metabolic support | 1/10 | 5/10 | Stronger for Bitter Melon |
| Skin irritation | 1/10 | 1/10 | Comparable evidence |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
Principal immunomodulatory constituents, the main focus of anticancer-adjunct and immune research.
Bitter triterpenes associated with anti-inflammatory, hepatoprotective and adaptogenic activity.
Now regarded as the main antidiabetic principles.
A mixture of two sterol glucosides, historically credited with the hypoglycaemic effect.
An insulin-like polypeptide of the fruit and seed.
A pyrimidine glycoside that can trigger favism in G6PD-deficient people.
Pharmacological Actions
Antidiabetic / blood-sugar lowering (improves glucose uptake and GLUT4 translocation)
Bitter digestive / stomachic (traditional use for poor digestion); mild laxative
Bitter digestive / stomachic (traditional use for poor digestion); mild laxative
Bitter digestive / stomachic (traditional use for poor digestion); mild laxative
Traditional & Indicated Uses
inferred from anti-inflammatory action
inferred from antidiabetic action
inferred from anticancer action
inferred from antiviral action
inferred from anti-inflammatory action
inferred from sedative action
inferred from antidiabetic action
inferred from bitter-tonic action
inferred from anti-inflammatory action
Antidiabetic / blood-sugar lowering (improves glucose uptake and GLUT4 translocation)
inferred from anticancer action
inferred from anti-inflammatory action
inferred from antidiabetic action
inferred from anti-inflammatory action
Safety, Cautions & Contraindications
Generally well tolerated at standard doses. May cause mild digestive upset, dry mouth, or dizziness in some individuals. May enhance the effects of anticoagulant and antihypertensive medications. Avoid during pregnancy and breastfeeding. Extended use beyond 6 months is not well studied in humans.
Duke (2002) rates reishi (Ganoderma lucidum) as + and notes immunostimulant, hepatoprotective, antioxidant, antitumor, and hypoglycemic activities at the experimental level (score 1). It is a key adaptogen in traditional Chinese medicine, valued for its polysaccharide (beta-glucan) content. Duke notes antiviral (score 1) and anti-aggregant activities. No strong clinical trials existed at time of publication, but lentinan and polysaccharide fractions from related species show immunomodulatory potential. Duke suggests caution in bleeding disorders due to anti-aggregant activity (Duke, 2002).
Avoid in pregnancy: bitter melon can stimulate the uterus and has been associated with miscarriage; also avoid during breastfeeding.
Strong blood-sugar-lowering action: used with insulin or other diabetes medicines it can cause hypoglycaemia - monitor blood glucose and seek medical advice.
People with glucose-6-phosphate dehydrogenase (G6PD) deficiency should avoid the seeds, which contain vicine and can cause favism (haemolytic anaemia). Excessive intake may cause abdominal pain and diarrhoea.
External Ids
Botanical Description
Bracket (shelf) fungus (not a true plant) that grows on the trunks and stumps of deciduous trees. It develops a hard, kidney- or fan-shaped cap with a glossy, varnished, red-brown to mahogany crust and concentric growth rings, often on a lateral woody stalk; the pale underside is covered in fine pores that release rusty-brown spores. The mycelium spreads through the wood substrate before fruiting.[1]
Climbing or trailing annual vine (Cucurbitaceae) that climbs by simple tendrils, typically 2-5 m long. Leaves are alternate, long-stalked and palmately lobed with 5-7 deep, toothed lobes. Flowers are small, yellow and five-petalled, male and female flowers separate on the same plant. The fruit is an oblong, warty-skinned gourd that ripens from green to orange-yellow and splits open to reveal seeds coated in a bright red aril; the unripe green fruit is the part used medicinally and as food.
Habitat
Grows as a wood-decay fungus on the stumps and trunks of deciduous trees (notably maple and other hardwoods) in East Asian forests; also widely cultivated commercially on hardwood logs or sawdust substrate.
Likely native to tropical Asia (possibly the Indian subcontinent), now widely cultivated across tropical and subtropical Asia, Africa, the Caribbean and increasingly the Americas as a vegetable and medicinal crop; needs warmth, full sun and a trellis or support to climb.[11]
Harvesting
Wild fruiting bodies are collected once mature; cultivated material is harvested from logs or substrate at maturity, then dried and processed into slices, powder or extract.
The fruit is harvested unripe, while still green and firm, before it yellows and splits, for use as a vegetable and in traditional antidiabetic preparations; leaves are also traditionally gathered.[11]
Traditional Uses
Reishi/lingzhi, the 'mushroom of immortality', is one of the most revered tonic fungi in traditional Chinese medicine, used for centuries to support vitality, calm the spirit, strengthen immunity and promote longevity; this traditional tonic reputation is now studied for immunomodulatory, anticancer-adjunct and metabolic effects.[1, 4]
Bitter melon has a long history in Asian, African and Caribbean traditional medicine as a bitter digestive tonic and mild laxative, and most notably as a remedy for diabetes and its complications; this traditional antidiabetic use is now the most scientifically supported of its properties, with numerous studies on its blood-glucose- and lipid-lowering effects.[4, 11]
Preparations
References
Drug Class Interactions
Lookalikes Review
Dangerous Lookalikes
Not documented
Dosage
Not documented
Clinical trials studying bitter melon for blood-sugar support have used standardised fruit extract or juice preparations taken daily over several weeks; dosing varies by product. Because it can lower blood glucose, monitor levels closely if combining with diabetes medication. Educational reference only, not a prescription.
References & Sources
- Li, W., Zhou, Q., Lv, B., Li, N. et al (2024) 'Ganoderma lucidum Polysaccharide Supplementation Significantly Activates T-Cell-Mediated Antitumor Immunity and Enhances Anti-PD-1 Immunotherapy Efficacy in Colorectal Cancer', Journal of Agricultural and Food Chemistry, 72(21), pp. 12072-12082. doi:10.1021/acs.jafc.3c08385 Preclinical
https://doi.org/10.1021/acs.jafc.3c08385 - Cai, Q., Li, Y. and Pei, G (2017) 'Polysaccharides from Ganoderma lucidum attenuate microglia-mediated neuroinflammation and modulate microglial phagocytosis and behavioural response', Journal of Neuroinflammation, 14(1), pp. 63. doi:10.1186/s12974-017-0839-0 Preclinical
https://doi.org/10.1186/s12974-017-0839-0 - Zheng, G., Zhao, Y., Li, Z., Hua, Y. et al (2023) 'Ganoderma lucidum spore powder and derived triterpenes attenuate atherosclerosis and aortic calcification by stimulating ABCA1/G1-mediated macrophage cholesterol efflux and inactivating RUNX2-mediated VSMC osteogenesis', Theranostics, 13(4), pp. 1325-1341. doi:10.7150/thno.80250 Preclinical
https://doi.org/10.7150/thno.80250 - Sohretoglu, D. and Huang, S (2018) 'Ganoderma lucidum Polysaccharides as An Anti-cancer Agent', Anti-Cancer Agents in Medicinal Chemistry, 18(5), pp. 667-674. doi:10.2174/1871520617666171113121246 Meta-analysis / review
https://doi.org/10.2174/1871520617666171113121246 - Seweryn, E., Ziala, A. and Gamian, A (2021) 'Health-Promoting of Polysaccharides Extracted from Ganoderma lucidum', Nutrients, 13(8), pp. 2725. doi:10.3390/nu13082725 Meta-analysis / review
https://doi.org/10.3390/nu13082725 - Liu, X., Yang, L., Li, G., Jiang, Y., Zhang, G. and Ling, J (2022) 'A novel promising neuroprotective agent: Ganoderma lucidum polysaccharide', International Journal of Biological Macromolecules, 229, pp. 168-180. doi:10.1016/j.ijbiomac.2022.12.276 Meta-analysis / review
https://doi.org/10.1016/j.ijbiomac.2022.12.276 - Zhu, M., Chang, Q., Wong, L.K., Chong, F.S. and Li, R.C (1999) 'Triterpene antioxidants from Ganoderma lucidum', Phytotherapy Research, 13(6), pp. 529-531. doi:10.1002/(sici)1099-1573(199909)13:6<529::aid-ptr481>3.0.co;2-x Preclinical
https://doi.org/10.1002/(sici)1099-1573(199909)13:6<529::aid-ptr481>3.0.co;2-x - Zeng, P., Chen, Y., Zhang, L. and Xing, M (2019) 'Ganoderma lucidum polysaccharide used for treating physical frailty in China', Progress in Molecular Biology and Translational Science, 163, pp. 179-219. doi:10.1016/bs.pmbts.2019.02.009 Meta-analysis / review
https://doi.org/10.1016/bs.pmbts.2019.02.009 - Wu, P., Zhang, C., Yin, Y., Zhang, X., Li, Q., Yuan, L., Sun, Y., Zhou, S., Ying, S. and Wu, J (2024) 'Bioactivities and industrial standardization status of Ganoderma lucidum: A comprehensive review', Heliyon, 10(19), pp. e36987. doi:10.1016/j.heliyon.2024.e36987 Meta-analysis / review
https://doi.org/10.1016/j.heliyon.2024.e36987 - Xu, Z., Chen, X., Zhong, Z., Chen, L. and Wang, Y (2011) 'Ganoderma lucidum polysaccharides: immunomodulation and potential anti-tumor activities', The American Journal of Chinese Medicine, 39(1), pp. 15-27. doi:10.1142/S0192415X11008610 Meta-analysis / review
https://doi.org/10.1142/S0192415X11008610 - Geng, X., Zhong, D., Su, L., Lin, Z. and Yang, B (2019) 'Preventive and therapeutic effect of Ganoderma lucidum on kidney injuries and diseases', Advances in Pharmacology, 87, pp. 257-276. doi:10.1016/bs.apha.2019.10.003 Meta-analysis / review
https://doi.org/10.1016/bs.apha.2019.10.003 - Sliva, D (2004) 'Cellular and physiological effects of Ganoderma lucidum (Reishi)', Mini Reviews in Medicinal Chemistry, 4(8), pp. 873-879. doi:10.2174/1389557043403323 Meta-analysis / review
https://doi.org/10.2174/1389557043403323 - Boh, B., Berovic, M., Zhang, J. and Zhi-Bin, L (2007) 'Ganoderma lucidum and its pharmaceutically active compounds', Biotechnology Annual Review, 13, pp. 265-301. doi:10.1016/S1387-2656(07)13010-6 Meta-analysis / review
https://doi.org/10.1016/S1387-2656(07)13010-6 - Bao, X. et al (2001) 'Structural requirements for the immunological activities of polysaccharides from Ganoderma lucidum', 41(9), pp. 2603--2611. Traditional / reference
https://scholar.google.com/scholar?q=Structural%20requirements%20for%20the%20immunological%20activities%20of%20polysaccharides%20from%20Ganoderma%20lucidum - Jin, X. et al (2012) 'Ganoderma lucidum (Reishi mushroom) for cancer treatment'. Traditional / reference
https://scholar.google.com/scholar?q=Ganoderma%20lucidum%20%28Reishi%20mushroom%29%20for%20cancer%20treatment - Wachtel-Galor, S., Yuen, J., Buswell, J.A. and Benzie, I.F.F (2011) 'Ganoderma lucidum (Lingzhi or Reishi): A Medicinal Mushroom'. Traditional / reference
https://scholar.google.com/scholar?q=Ganoderma%20lucidum%20%28Lingzhi%20or%20Reishi%29%3A%20A%20Medicinal%20Mushroom - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Ghasemzadeh Rahbardar, M. and Hosseinzadeh, H (2024) 'Therapeutic potential of hypnotic herbal medicines: A comprehensive review', Phytotherapy Research, 38(6), pp. 3037-3059. doi:10.1002/ptr.8201 Meta-analysis / review
https://doi.org/10.1002/ptr.8201 - Block, K.I., Gyllenhaal, C. and Mead, M.N (2004) 'Safety and efficacy of herbal sedatives in cancer care', Integrative Cancer Therapies, 3(2), pp. 128-148. doi:10.1177/1534735404265003 Meta-analysis / review
https://doi.org/10.1177/1534735404265003 - Ahn, J.Y. and Seok, S.J. and Song, J.E. and Choi, J.H. and Han, S.H. and Choi, J.Y. and Kim, C.O. and Song, Y.G. and Kim, J.M (2013) 'Two cases of mushroom poisoning by Podostroma cornu-damae', Yonsei Medical Journal, 54(1), pp. 265-8. doi:10.3349/ymj.2013.54.1.265 Clinical study
https://doi.org/10.3349/ymj.2013.54.1.265 - Choe, S. and In, S. and Jeon, Y. and Choi, H. and Kim, S (2018) 'Identification of trichothecene-type mycotoxins in toxic mushroom Podostroma cornu-damae and biological specimens from a fatal case by LC-QTOF/MS', Forensic Science International, 291, pp. 234-244. doi:10.1016/j.forsciint.2018.08.043 Clinical study
https://doi.org/10.1016/j.forsciint.2018.08.043
- Kim, S.K., Jung, J., Jung, J.H., Yoon, N. and others (2020) 'Hypoglycemic efficacy and safety of Momordica charantia (bitter melon) in patients with type 2 diabetes mellitus', Complementary Therapies in Medicine, 52, pp. 102524. doi:10.1016/j.ctim.2020.102524 Randomized trial
https://doi.org/10.1016/j.ctim.2020.102524 - Fang, E.F., Froetscher, L., Scheibye-Knudsen, M., Bohr, V.A. and others (2019) 'Emerging Antitumor Activities of the Bitter Melon (Momordica charantia)', Current Protein & Peptide Science, 20(3), pp. 296-301. doi:10.2174/1389203719666180622095800 Meta-analysis / review
https://doi.org/10.2174/1389203719666180622095800 - Raina, K., Kumar, D. and Agarwal, R (2016) 'Promise of bitter melon (Momordica charantia) bioactives in cancer prevention and therapy', Seminars in Cancer Biology, 40-41, pp. 116-129. doi:10.1016/j.semcancer.2016.07.002 Meta-analysis / review
https://doi.org/10.1016/j.semcancer.2016.07.002 - Basch, E., Gabardi, S. and Ulbricht, C (2003) 'Bitter melon (Momordica charantia): a review of efficacy and safety', American Journal of Health-System Pharmacy, 60(4), pp. 356-359. doi:10.1093/ajhp/60.4.356 Meta-analysis / review
https://doi.org/10.1093/ajhp/60.4.356 - Bora, A.F.M., Kouame, K.J.E., Li, X., Liu, L. and others (2023) 'New insights into the bioactive polysaccharides, proteins, and triterpenoids isolated from bitter melon (Momordica charantia) and their relevance for nutraceutical and food application: A review', International Journal of Biological Macromolecules, 231, pp. 123173. doi:10.1016/j.ijbiomac.2023.123173 Meta-analysis / review
https://doi.org/10.1016/j.ijbiomac.2023.123173 - Soo May, L., Sanip, Z., Ahmed Shokri, A., Abdul Kadir, A. and others (2018) 'The effects of Momordica charantia (bitter melon) supplementation in patients with primary knee osteoarthritis: A single-blinded, randomized controlled trial', Complementary Therapies in Clinical Practice, 32, pp. 181-186. doi:10.1016/j.ctcp.2018.06.012 Randomized trial
https://doi.org/10.1016/j.ctcp.2018.06.012 - Elekofehinti, O.O., Ariyo, E.O., Akinjiyan, M.O., Olayeriju, O.S. and others (2018) 'Potential use of bitter melon (Momordica charantia) derived compounds as antidiabetics: In silico and in vivo studies', Pathophysiology, 25(4), pp. 327-333. doi:10.1016/j.pathophys.2018.05.003 Preclinical
https://doi.org/10.1016/j.pathophys.2018.05.003 - Leung, L., Birtwhistle, R., Kotecha, J., Hannah, S. and others (2009) 'Anti-diabetic and hypoglycaemic effects of Momordica charantia (bitter melon): a mini review', British Journal of Nutrition, 102(12), pp. 1703-1708. doi:10.1017/S0007114509992054 Meta-analysis / review
https://doi.org/10.1017/S0007114509992054 - Krawinkel, M.B. and Keding, G.B (2006) 'Bitter gourd (Momordica charantia): A dietary approach to hyperglycemia', Nutrition Reviews, 64(7 Pt 1), pp. 331-337. doi:10.1301/nr.2006.jul.331-337 Meta-analysis / review
https://doi.org/10.1301/nr.2006.jul.331-337 - Fang, E.F. and Ng, T.B (2011) 'Bitter gourd (Momordica charantia) is a cornucopia of health: a review of its credited antidiabetic, anti-HIV, and antitumor properties', Current Molecular Medicine, 11(5), pp. 417-436. doi:10.2174/156652411795976583 Meta-analysis / review
https://doi.org/10.2174/156652411795976583 - Cicek, S.S (2022) 'Momordica charantia L. - Diabetes-Related Bioactivities, Quality Control, and Safety Considerations', Frontiers in Pharmacology. doi:10.3389/fphar.2022.904643 Traditional / reference
https://doi.org/10.3389/fphar.2022.904643 - WebMD (n.d.) 'Bitter Melon: Overview, Uses, Side Effects, Precautions, Interactions'. Available at: https://www.webmd.com/vitamins/ai/ingredientmono-795/bitter-melon Traditional / reference
https://www.webmd.com/vitamins/ai/ingredientmono-795/bitter-melon - Yedjou, C.G., Grigsby, J., Mbemi, A., Nelson, D., Mildort, B., Latinwo, L. and Tchounwou, P.B (2023) 'The Management of Diabetes Mellitus Using Medicinal Plants and Vitamins', International Journal of Molecular Sciences. doi:10.3390/ijms24109085 Randomized trial
https://doi.org/10.3390/ijms24109085 - Kim, S.K., Jung, J., Jung, J.H., Yoon, N., Kang, S.S., Roh, G.S. and Hahm, J.R (2020) 'Hypoglycemic efficacy and safety of Momordica charantia (bitter melon) in patients with type 2 diabetes mellitus', Complementary Therapies in Medicine, 52, pp. 102524. doi:10.1016/j.ctim.2020.102524 Randomized trial
https://doi.org/10.1016/j.ctim.2020.102524 - Zhang, X., Zhao, Y., Song, Y. and Miao, M (2024) 'Effects of Momordica charantia L. supplementation on glycemic control and lipid profile in type 2 diabetes mellitus patients: a systematic review and meta-analysis of randomized controlled trials', Heliyon, 10(10), pp. e31126. doi:10.1016/j.heliyon.2024.e31126 Meta-analysis / review
https://doi.org/10.1016/j.heliyon.2024.e31126
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.